These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 8326511)

  • 1. Pathogenesis of alphavirus infection as demonstrated by infection of ECV 304 transformed human umbilical vein capillary endothelial cells with Semliki Forest virus.
    Jakob R
    J Med Microbiol; 1993 Jul; 39(1):26-32. PubMed ID: 8326511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholesterol-depleted cells that are relatively permissive for Semliki Forest virus infection.
    Marquardt MT; Kielian M
    Virology; 1996 Oct; 224(1):198-205. PubMed ID: 8862414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of Semliki Forest virus RNA replication: a model for the control of alphavirus pathogenesis in invertebrate hosts.
    Kim KH; Rümenapf T; Strauss EG; Strauss JH
    Virology; 2004 May; 323(1):153-63. PubMed ID: 15165827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translation of capped virus mRNA in encephalomyocarditis virus-infected cells.
    Alonso MA; Carrasco L
    J Gen Virol; 1982 Jun; 60(Pt 2):315-25. PubMed ID: 6286854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The genomic sequence of defective interfering Semliki Forest virus (SFV) determines its ability to be replicated in mouse brain and to protect against a lethal SFV infection in vivo.
    Thomson M; White CL; Dimmock NJ
    Virology; 1998 Feb; 241(2):215-23. PubMed ID: 9499796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional significance of the nuclear-targeting and NTP-binding motifs of Semliki Forest virus nonstructural protein nsP2.
    Rikkonen M
    Virology; 1996 Apr; 218(2):352-61. PubMed ID: 8610462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A kinetic and ultrastructural comparison of alphavirus infection of cultured mosquito and vertebrate cells.
    Lehane MJ; Leake CJ
    J Trop Med Hyg; 1982 Dec; 85(6):229-38. PubMed ID: 7154145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth and stability of a cholesterol-independent Semliki Forest virus mutant in mosquitoes.
    Ahn A; Schoepp RJ; Sternberg D; Kielian M
    Virology; 1999 Sep; 262(2):452-6. PubMed ID: 10502523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncolytic capacity of attenuated replicative semliki forest virus in human melanoma xenografts in severe combined immunodeficient mice.
    Vähä-Koskela MJ; Kallio JP; Jansson LC; Heikkilä JE; Zakhartchenko VA; Kallajoki MA; Kähäri VM; Hinkkanen AE
    Cancer Res; 2006 Jul; 66(14):7185-94. PubMed ID: 16849565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limited infection of mouse brain cell cultures with Semliki forest virus.
    Seamer J
    Br J Exp Pathol; 1974 Dec; 55(6):606-14. PubMed ID: 4447795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Semliki Forest virus infects mouse brain endothelial cells and causes blood-brain barrier damage.
    Soilu-Hänninen M; Erälinna JP; Hukkanen V; Röyttä M; Salmi AA; Salonen R
    J Virol; 1994 Oct; 68(10):6291-8. PubMed ID: 7916058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel vectors expressing anti-apoptotic protein Bcl-2 to study cell death in Semliki Forest virus-infected cells.
    Kiiver K; Merits A; Sarand I
    Virus Res; 2008 Jan; 131(1):54-64. PubMed ID: 17904678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of death in Semliki Forest virus-infected mice by administration of defective-interfering Semliki Forest virus.
    Dimmock NJ; Kennedy SI
    J Gen Virol; 1978 May; 39(2):231-42. PubMed ID: 650175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of low pH and disulfide shuffling in the entry and fusion of Semliki Forest virus and Sindbis virus.
    Glomb-Reinmund S; Kielian M
    Virology; 1998 Sep; 248(2):372-81. PubMed ID: 9721245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Entry of Semliki forest virus into cells: effects of concanamycin A and nigericin on viral membrane fusion and infection.
    Irurzun A; Nieva JL; Carrasco L
    Virology; 1997 Jan; 227(2):488-92. PubMed ID: 9018148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis of Semliki Forest virus encephalitis.
    Fazakerley JK
    J Neurovirol; 2002 Dec; 8 Suppl 2():66-74. PubMed ID: 12491154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of therapeutic antitumor antiangiogenesis by intratumoral injection of genetically engineered endostatin-producing Semliki Forest virus.
    Yamanaka R; Zullo SA; Ramsey J; Onodera M; Tanaka R; Blaese M; Xanthopoulos KG
    Cancer Gene Ther; 2001 Oct; 8(10):796-802. PubMed ID: 11687903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Semliki Forest virus multiplication in L-cells by combinations of interferon and ribavirin as measured by plaque titration and direct enzyme immunoassay.
    Harmsen T; Van Veenendaal D; Kraaijeveld CA
    Zentralbl Bakteriol; 1994 Jan; 280(3):386-91. PubMed ID: 7513217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Togavirus interference in Culex annulirostris mosquitoes.
    Davey MW; Mahon RJ; Gibbs AJ
    J Gen Virol; 1979 Mar; 42(3):641-3. PubMed ID: 430033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assay of defective-interfering semliki forest virus by the inhibition of synthesis of virus-specified RNAs.
    Barrett AD; Crouch CF; Dimmock NJ
    J Gen Virol; 1981 Jun; 54(Pt 2):273-80. PubMed ID: 6169791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.